Document is current

Article History

Received: 25 March 2022

Accepted: 8 March 2023

First Online: 30 May 2023

Declarations

:

: <b>Carolyn S. P. Lam</b> has received research support from Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, and Vifor Pharma; has served as consultant or on the Advisory Board / Steering Committee / Executive Committee for Abbott Diagnostics, Amgen, Applied Therapeutics, AstraZeneca, Bayer, Biofourmis, Boehringer Ingelheim, Boston Scientific, Corvia Medical, Cytokinetics, Darma Inc., Us2.ai, JanaCare, Janssen Research & Development LLC, Medtronic, Menarini Group, Merck, MyoKardia, Novartis, Novo Nordisk, Radcliffe Group Ltd., Roche Diagnostics, Sanofi, Stealth BioTherapeutics, The Corpus, Vifor Pharma and WebMD Global LLC; and serves as co-founder and non-executive director of Us2.ai.<b>Ed Harding</b> is a Managing Director of the Health Policy Partnership Ltd, (London, UK) which has provided consultancy services in the field of cardiovascular health policy to Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Novo Nordisk, Roche Diagnostics, St. Jude Medical and CSL Vifor.<b>Marc Bains</b> is a consultant for AstraZeneca and is the co-founder of HeartLife Foundation, which has received grants from AstraZeneca.<b>Alex Chin</b> is an employee of AstraZeneca.<b>Naresh Kanumilli</b> has received honoraria and travel grants from AstraZeneca, Boehringer Ingelheim, Lilly, Mylan, Napp, Novo Nordisk and Sanofi.<b>Mark C. Petrie</b> has received research funding from Boehringer Ingelheim, Roche, SQ Innovations, AstraZeneca, Novartis, Novo Nordisk, Medtronic, Boston Scientific, Pharmacosmos; and served on consultancy and end point committees for Boehringer Ingelheim, Novartis, AstraZeneca, Novo Nordisk, Abbvie, Bayer, Takeda, Cardiorentis and Pharmacosmos.<b>Paula Pohja-Hutchison</b> is an employee of AstraZeneca.<b>Jiefu Yang</b> is a consultant for AstraZeneca.<b>Javed Butler</b> is a consultant for Abbott, Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, CVRx, Eli Lilly, G3 Pharmaceutical, Impulse Dynamics, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Relypsa, Sequana, StealthPeptide and Vifor.

: All methods were carried out in accordance with the Market Research Society Professional Code of Conduct and relevant data protection laws. All experimental protocols adhere to all relevant codes of practice and standards of several market research industry bodies, including ESOMAR (Global), Insights Association (USA), the Market Research Society (UK) and the British Polling Council (UK), and as such were outside the scope of research ethics committee or IRB review in all countries where the research was conducted.[CitationRef removed] No personal details of the participants were collected or stored. Informed consent was obtained from all participants.

: Not applicable.